|
NIPA2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.845400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.598400E-01 |
| Normal-vs-Stage2 |
7.288600E-01 |
| Normal-vs-Stage3 |
1.930220E-01 |
| Normal-vs-Stage4 |
2.852100E-02 |
| Stage1-vs-Stage2 |
9.521600E-01 |
| Stage1-vs-Stage3 |
2.642800E-01 |
| Stage1-vs-Stage4 |
4.838000E-02 |
| Stage2-vs-Stage3 |
4.853600E-01 |
| Stage2-vs-Stage4 |
1.310160E-01 |
| Stage3-vs-Stage4 |
2.863400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.430800E-01 |
| Normal-vs-AfricanAmerican |
3.736400E-01 |
| Normal-vs-Asian |
8.946000E-01 |
| Caucasian-vs-AfricanAmerican |
1.863600E-01 |
| Caucasian-vs-Asian |
4.520600E-01 |
| AfricanAmerican-vs-Asian |
3.549800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.006400E-01 |
| Normal-vs-Female |
5.486800E-01 |
| Male-vs-Female |
3.311800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.042400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.429980E-01 |
| Normal-vs-Age(61-80Yrs) |
3.839600E-01 |
| Normal-vs-Age(81-100Yrs) |
7.128400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.285800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.027200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.456800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.057800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.844200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.392800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.103600E-02 |
| Classical-VS-Follicular |
4.376300E-02 |
| Classical-VS-Other |
2.394400E-01 |
| Classical-VS-Normal |
9.258200E-01 |
| Tall-VS-Follicular |
6.730000E-01 |
| Tall-VS-Other |
7.977000E-01 |
| Tall-VS-Normal |
7.449600E-02 |
| Follicular-VS-Other |
6.478200E-01 |
| Follicular-VS-Normal |
1.265760E-01 |
| Other-VS-Normal |
1.647840E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.109400E-01 |
| Normal-vs-N1 |
1.759610E-02 |
| N0-vs-N1 |
7.132400E-02 |
|
|
